ECOG-ACRIN Cancer Research Group shared a post on X:
“ComboMATCH Treatment Trial E5, led by Kristen Spencer of Perlmutter Cancer Center at NYU Langone Health and Dustin Deming of UW Health | Carbone Cancer Center, is a randomized phase 2 study of sotorasib with or without panitumumab in advanced Solid Tumors.
Learn more here.”